Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency

Blood

Volumn 91, Issue 1, 1998, Pages 30-36

  Onodera, Masafumi ^b   Ariga, Tadashi ^b   Kawamura, Nobuaki ^b   Kobayashi, Ichiro ^b   Yamada, Masafumi ^b   Tame, Atsushi ^b   Furuta, Hirofumi ^b   Okano, Motohiko ^b   Matsumoto, Shuzo ^b   Kotani, Hitoshi ^b   McGarrity, Gerard J ^b   Blaese, R Michael ^b   Sakiyama, Yukio ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE;

ARTICLE; CASE REPORT; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNITY; LYMPHOCYTE COUNT; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031975088     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.1.30.30_30_36     Document Type: Article

References (33)

1. Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ: Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067, 1972
2. Kredich NM, Hershfield MS: Immunodeficiency disease associated with adenosine deaminase deficiency and purine nucleoside phosphorylase dcficiency, in Scriver CM, Beaudet AL, Sly WS, Valle D (eds): The metabolic basis of inherited disease (ed 5). New York, NY, McGraw Hill, 1989, p 1045
3. Hirschhorn R: Adenosine deaminase deficiency, in Rosen FS, Seligmann M (eds): Immunodeficiency Reviews, vol 2. London, UK, Harwood Academic, 1990, p 175
4. Morgan G, Levinsky RJ, Hugh-Jones K, Fairbanks LD, Morris GS, Simmonds HA: Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency. Clin Exp Immunol 70:491, 1987
5. Hirschhorn R, Ellenbogen A: Genetic heterogeneity in adenosine deaminase (ADA) deficiency: Five different mutations in five new patients with partial ADA deficiency. Am J Hum Genet 38:13, 1986
6. Hirschhorn R: Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency. Pediatr Res 33:S35, 1993 (suppl 1)
7. Chen SH, Ochs HD, Scott CR, Giblett ER, Tingle AJ: Adenosine deaminase deficiency: Disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation. J Clin Invest 62:138, 1978
8. Hershfield MS, Buckley RH, Greenberg ML, Melton AL, Schiff R, Hatem C, Kurtberg J, Markert ML, Kabayashi RH, Kobayashi AL, Abuchowski A: Treatment of adenosine deaminase deficiency with polyethyleneglycol-modified adenosine deaminase. N Engl J Med 316:589, 1987
9. Hershfield MS, Chaffee S, Sorensen RU: Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy. Pediatr Res 33:542, 1993 (suppl 1)
10. Daddona PE, Shewach DS, Kelley WN, Argos P, Markham AF, Orkin SH: Human adenosine deaminase. cDNA and complete primary amino acid sequence. J Biol Chem 259:12101, 1984
11. Valerio D, McIvor RS, Williams SR, Duyvesteyn MG, van Ormondt H, van der Eb AJ, Martin DW Jr: Cloning of human adenosine deaminase cDNA and expression in mouse cells. Gene 31:147, 1984
12. Wiginton DA, Adrian GS, Hutton JJ: Sequence of human adenosine deaminase cDNA including the coding region and a small intron. Nucleic Acids Res 12:2439, 1984
13. Wiginton DA, Kaplan DJ, States JC, Akeson AL, Perme CM, Bilyk IJ, Vaughn AJ, Lattier DL, Hutton JJ: Complete sequence and structure of the gene for human adenosine deaminase. Biochemistry 25:8234, 1986
14. -SCID: Initial trial results after 4 years. Science 270:475, 1995
15. - immunodeficient patients. Science 270:470, 1995
16. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, el-Khoureiy A, Lawrence K, Wells D, Moen RC, Bastion J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1:1017, 1995
17. Hoogerbrugge PM, van Beusechem VW, Fischer A, Debree M, le Deist F, Perignon JL, Morgan G, Gaspar B, Fairbanks LD, Skeoch CH, Moseley A, Harvey M, Levinsky RJ, Valerio D: Bone marrow gene tiansfer in three patients with adenosine deaminase deficiency. Gene Ther 3:179, 1996
18. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
19. - patients with severe combined immunodeficiency. Am J Med Genet 49:201, 1992
20. Santisteban I, Arredondo-Vega FX, Kelly S, Mary A, Fischer A, Hummell DS, Lawton A, Sorensen RU, Stiehm ER, Uribe L, Weinberg K, Hershfield MS: Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype. J Clin Invest 92:2291, 1993
21. Hirschhorn R, Yang DR, Israni A: An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): Occurrence on different chromosomal backgrounds and apparent intragenic crossover. Ann Hum Genet 58:1, 1994
22. Blaese RM, Anderson WF, Culver KW: The ADA human gene therapy clinical protocol. Hum Gene Ther 1:327, 1990
23. Hock RA, Miller AD, Osborne WR: Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines. Blood 74:876, 1989
24. Bunnell BA, Muul LM, Donahue RE, Blaese RM, Morgan RA: High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc Natl Acad Sci USA 92:7739, 1995
25. Kohn DB, Mitsuya H, Ballow M, Selegue JE, Barankiewicz J, Cohen A, Gelfand E, Anderson WF, Blaese RM: Establishment and characterization of adenosine deaminase-deficient human T cell lines. J Immunol 142:3971, 1989
26. Aebi M, Hornig H, Padgett RA, Reiser J, Weissmann C: Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNA. Cell 47:555, 1986
27. Krawczak M, Reiss J, Cooper DN: The rautational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences. Hum Genet 90:41, 1992
28. Miller AD: Human gene therapy comes of age. Nature 357:455, 1992
29. Marcel T, Grausz ID: The TWC worldwide gene therapy enrollment report, end 1996. Hum Gene Ther 8:775, 1997
30. Blaese RM: Development of gene therapy for immunodeficiency: Adenosine deaminase deficiency. Pediatr Res 33:S49, 1993 (suppl 1)
31. Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, Manley SA, Lupton SD, Overell RW, Reynolds TC, Corey L, Greenberg PD: T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 2:216, 1996
32. Ferrari G, Rossini S, Giavazzi R, Maggioni D, Nobili N, Soldati M, Ungers G, Mavilio F, Gilboa E, Bordignon C: An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. Science 251:1363, 1991
33. Hirschhorn R, Yang DR, Puck JM, Huie ML, Jiang CK, Kurlandsky LE: Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet 13:290, 1996